We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Zyus Life Sciences Corporation | TSXV:ZYUS | TSX Venture | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.84 | 0.81 | 0.85 | 0 | 16:47:23 |
TORONTO, July 19, 2023 /CNW/ - Brent Zettl, President and Chief Executive Officer, ZYUS Life Sciences Corp. ("ZYUS" or the "Company") (TSXV: ZYUS), and his team joined Robert Peterman, Vice President, Global Business Development, Toronto Stock Exchange (TSX), to close the market and celebrate the Company's listing on TSX Venture Exchange.
ZYUS is a Canadian life sciences company committed to reinventing the treatment of chronic and neuropathic pain by harnessing the therapeutic properties of cannabinoid formulations.
Through scientific discovery and clinical research, they are focused on shifting the paradigm in pain management with the development of pharmaceutical drug product candidates and intellectual property activities to protect our novel cannabinoid-based therapies.
SOURCE Toronto Stock Exchange
Copyright 2023 Canada NewsWire
1 Year Zyus Life Sciences Chart |
1 Month Zyus Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions